Apheresis machine for extracorporeal elimination of LDL cholesterol in patients with familial hypercholesterolemia, hyperlipoproteinemia (a), hyperfibrinogenemia, transplant vasculopathy.

An apheresis machine is a device which receives blood removed from a patient or donor’s body and separates it into its various components: plasma, platelets, white blood cells and red blood cells.

Previous studies have suggested that leukocyte apheresis, which selectively removes about 65% of activated granulocytes and 55% of activated monocytes from peripheral blood, can improve IBD ...

The global Apheresis Equipment Market is valued at $2.01 million in 2023 and is projected to reach a value of $2.20 million by 2032, growing at a Compound Annual Growth Rate (CAGR) of 3.7% from 2024 ...